Sumitomo Mitsui Trust Group Inc. raised its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 2.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 622,008 shares of the industrial products company’s stock after acquiring an additional 12,284 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.26% of Xylem worth $91,746,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in XYL. AFG Fiduciary Services Limited Partnership acquired a new position in shares of Xylem during the 2nd quarter valued at about $275,000. IFM Investors Pty Ltd raised its stake in Xylem by 11.6% during the second quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company’s stock worth $6,995,000 after purchasing an additional 5,617 shares during the period. Impax Asset Management Group plc boosted its holdings in Xylem by 13.7% in the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock valued at $709,183,000 after purchasing an additional 663,191 shares during the last quarter. Ferguson Wellman Capital Management Inc. purchased a new stake in shares of Xylem in the 3rd quarter valued at approximately $1,148,000. Finally, XXEC Inc. increased its holdings in shares of Xylem by 66.0% during the 2nd quarter. XXEC Inc. now owns 33,698 shares of the industrial products company’s stock worth $4,359,000 after buying an additional 13,404 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Xylem Price Performance
XYL stock opened at $140.03 on Wednesday. The business’s fifty day moving average price is $140.68 and its 200 day moving average price is $140.97. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $34.09 billion, a PE ratio of 36.00, a P/E/G ratio of 1.97 and a beta of 1.17.
Xylem Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s dividend payout ratio is presently 41.13%.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on XYL shares. Zacks Research lowered Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Cowen reaffirmed a “hold” rating on shares of Xylem in a research note on Friday, December 5th. Wall Street Zen downgraded Xylem from a “buy” rating to a “hold” rating in a research report on Saturday, December 27th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, UBS Group upped their target price on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $165.80.
Insider Buying and Selling
In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is owned by corporate insiders.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump Planning to Use Public Law 63-43: Prepare Now
- A month before the crash
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
